Abstract
Combination therapy tactics have been considered recently for increasing drug effectiveness and reducing the toxicity of chemotherapy. In this study, a novel core/shell metal–organic framework (MOF) was designed for the co-encapsulation of DOX with a pleiotropic agent like CUR. It is coated with folic acid-activated chitosan and pH-sensitive to enhance treatment efficiency and targeted drug delivery. It was coated with folic acid-activated chitosan and pH-sensitive for targeted delivery. A comparison of the release profiles of curcumin and doxorubicin in all cases shows a stable release and a pH-sensitive behavior during 72 h. The results showed the release rate of curcumin and doxorubicin from FC-MOF compared to the uncoated system at pH = 5 increased by 13% and 9%, respectively. We evaluated the efficacy and toxicity of the combined drug delivery system (CUR + DOX) using the MTT test in MCF7 (as a positive folic acid receptor) and HepG2 cells (as a negative folic acid receptor). FC-MOF-DOX at the highest concentrations of 14% and 26% survival was shown in MCF-7 and HepG2 cells, respectively. This increased toxicity confirms that folic acid receptors are involved in more cell uptake. Furthermore, the cytotoxicity results of FC-MOF (CUR + DOX) showed a synergistic effect through the co-delivery of cytotoxic drugs and sensitizing chemical agents. For example, FC-MOF (CUR + DOX) with a molar ratio of (25 CUR + 0.5 DOX g/ml) kills more than 60% of MCF7 cells, whereas MOF-CUR + DOX nanoparticles kill almost 45% of the cells. Hence, with low concentrations of DOX, more antitumor responses are created. Using this targeted drug delivery system, the drug can be delivered to cancer cells in a controlled and targeted way.
Graphical abstract
Similar content being viewed by others
References
S. Omidi, M. Pirhayati, A. Kakanejadifard, Carbohydr. Polym. 231, 115745 (2020)
J.-T. Lin, Q.-B. Ye, Q.-J. Yang, G.-H. Wang, Colloids Surf. B. 180, 93 (2019)
L. Lv, K. Qiu, X. Yu, C. Chen, F. Qin, Y. Shi, J. Ou, T. Zhang, H. Zhu, J. Wu, J. Biomed. Nanotechnol. 12(5), 973 (2016)
M. Kumari, M.P. Purohit, S. Patnaik, Y. Shukla, P. Kumar, K.C. Gupta, Eur. J. Pharm. Biopharm. 130, 185 (2018)
P. Zhang, J. Li, M. Ghazwani, W. Zhao, Y. Huang, X. Zhang, R. Venkataramanan, S. Li, Biomaterials 67, 104 (2015)
B.-L. Wang, Y.-M. Shen, Q.-W. Zhang, Y.-L. Li, M. Luo, Z. Liu, Y. Li, Z.-Y. Qian, X. Gao, H.-S. Shi, Int. J. Nanomedicine 8, 3521 (2013)
A. Varela-López, M. Battino, M.D. Navarro-Hortal, F. Giampieri, T.Y. Forbes-Hernández, J.M. Romero-Márquez, R. Collado, J.L. Quiles, Food Chem. Toxicol. 134, 110834 (2019)
Z. Shabaninejad, M.H. Pourhanifeh, A. Movahedpour, R. Mottaghi, A. Nickdasti, E. Mortezapour, A. Shafiee, S. Hajighadimi, S. Moradizarmehri, M. Sadeghian, Eur. J. Med. Chem. 188, 112040 (2020)
K.L. Reddy, P.K. Sharma, A. Singh, A. Kumar, K.R. Shankar, Y. Singh, N. Garg, V. Krishnan, Mater. Sci. Eng. C. 96, 86 (2019)
M. Jakubek, Z. Kejík, R. Kaplánek, R. Hromádka, V. Šandriková, D. Sýkora, V. Antonyová, M. Urban, P. Dytrych, I. Mikula, Biomed. Pharmacother. 118, 109278 (2019)
F.C. Rodrigues, N.A. Kumar, G. Thakur, Eur. J. Med. Chem. 177, 76 (2019)
Y. Hong, S. Che, B. Hui, Y. Yang, X. Wang, X. Zhang, Y. Qiang, H. Ma, Biomed. Pharmacother. 112, 108614 (2019)
W. Guo, Y. Song, W. Song, Y. Liu, Z. Liu, D. Zhang, Z. Tang, O. Bai, Sci. Rep. 10(1), 1 (2020)
A. Sesarman, L. Tefas, B. Sylvester, E. Licarete, V. Rauca, L. Luput, L. Patras, S. Porav, M. Banciu, A. Porfire, Drug Deliv. Transl. Res. 9(1), 260 (2019)
A. Sesarman, L. Tefas, B. Sylvester, E. Licarete, V. Rauca, L. Luput, L. Patras, M. Banciu, A. Porfire, Pharmacol. Rep. 70(2), 331 (2018)
C. Karavasili, D.A. Andreadis, O.L. Katsamenis, E. Panteris, Mol. Pharm. 16, 2326–2341 (2019)
X. Fang, J. Cao, A. Shen, J. Drug Deliv. Sci. Technol. 57, 101662 (2020)
H. Li, M. Li, C. Chen, A. Fan, D. Kong, Z. Wang, Y. Zhao, Int. J. Pharm. 495(1), 572 (2015)
I.A. Lazaro, R.S. Forgan, Coord. Chem. Rev. 380, 230 (2019)
M.A. Haydar, H.R. Abid, B. Sunderland, S. Wang, Drug Des. Devel. Ther. 11, 2685 (2017)
A. Tiwari, A. Singh, N. Garg, J.K. Randhawa, Sci. Rep. 7(1), 1 (2017)
O.J. de Lima Neto, A.C. de Oliveira Frós, B.S. Barros, A.F. de Farias Monteiro, J. Kulesza, New J. Chem. 43(14), 5518–5524 (2019)
Y. Liu, C.S. Gong, Y. Dai, Z. Yang, G. Yu, Y. Liu, M. Zhang, L. Lin, W. Tang, Z. Zhou, Biomaterials 218, 119365 (2019)
D. Cunha, M.B. Yahia, S. Hall, S.R. Miller, H. Chevreau, E. Elkaïm, G. Maurin, P. Horcajada, C. Serre, Chem. Mater. 25(14), 2767–2776 (2013). https://doi.org/10.1021/cm400798p
X. Ren, C. Yang, L. Zhang, S. Li, S. Shi, R. Wang, X. Zhang, T. Yue, J. Sun, J. Wang, Nanoscale 11(24), 11830 (2019)
V. Gupta, S. Mohiyuddin, A. Sachdev, P. Soni, P. Gopinath, S. Tyagi, J. Drug Deliv. Sci. Technol. 52, 846 (2019)
Y. Zhang, A.R. Khan, X. Yang, M. Fu, R. Wang, L. Chi, G. Zhai, J. Drug Deliv. Sci. Technol. 61, 102266 (2021)
Y. Wang, J. Yan, N. Wen, H. Xiong, S. Cai, Q. He, Y. Hu, D. Peng, Z. Liu, Y. Liu, Biomaterials 230, 119619 (2020)
M.P. Daryasari, M.R. Akhgar, F. Mamashli, B. Bigdeli, M. Khoobi, RSC Adv. 6(107), 105578 (2016)
Z. Cao, W. Li, R. Liu, X. Li, H. Li, L. Liu, Y. Chen, C. Lv, Y. Liu, Biomed. Pharmacother. 118, 109340 (2019)
V. Nejadshafiee, H. Naeimi, B. Goliaei, B. Bigdeli, A. Sadighi, S. Dehghani, A. Lotfabadi, M. Hosseini, M.S. Nezamtaheri, M. Amanlou, Mater. Sci. Eng. C. 99, 805 (2019)
M. Pooresmaeil, E.A. Asl, H. Namazi, J. Alloys Compd. 885, 160992 (2021)
H. Batra, S. Pawar, D. Bahl, Pharmacol. Res. 139, 91 (2019)
A.M. Khattabi, W.H. Talib, D.A. Alqdeimat, J. Drug Deliv. Sci. Technol. 41, 367 (2017)
Y. Li, S. Wang, F.X. Song, L. Zhang, W. Yang, H.X. Wang, Q.L. Chen, Colloids Surf. A Physicochem. Eng. Asp. 590, 124470 (2020)
L. Jaimes-Aguirre, E. Morales-Avila, B.E. Ocampo-García, L.A. Medina, G. López-Téllez, B.V. Gibbens-Bandala, V. Izquierdo-Sánchez, Mater. Sci. Eng. C. 76, 743 (2017)
S. Dehghani, M. Hosseini, S. Haghgoo, V. Changizi, H.A. Javar, M. Khoobi, N.R. Alam, J. Drug Target. 28(6), 668–680 (2020). https://doi.org/10.1080/1061186X.2019.1710839
F. Wang, Y. Chen, D. Zhang, Q. Zhang, D. Zheng, L. Hao, Y. Liu, C. Duan, L. Jia, G. Liu, Int. J. Nanomedicine. 7, 325 (2012)
H. Zhang, J. Wei, R. Liu, Z. Jing, Z. Di, Z. Li, Y. Luan, A.C.S. Appl, Mater. Interfaces. 9, 19687 (2017)
A. Farboudi, K. Mahboobnia, F. Chogan, M. Karimi, A. Askari, S. Banihashem, S. Davaran, M. Irani, Int. J. Biol. Macromol. 150, 178 (2020)
R.K. Thapa, Y. Choi, J.-H. Jeong, Y.S. Youn, H.-G. Choi, C.S. Yong, J.O. Kim, Pharm. Res. 33(11), 2815 (2016)
V. Tran, R. Kim, M. Maertens, T. Hartung, A. Maertens, Front. Artif. Intell. 4, 59 (2021)
X. Chen, L.Q. Zou, J. Niu, W. Liu, Sh.F. Peng, Ch.M. Liu, Molecules 20(8), 14293 (2015)
S.P. Victor, W. Paul, M. Jayabalan, C.P. Sharma, CrystEngComm 16, 9033 (2014)
A.H. Abouzeid, N.R. Patel, I.M. Rachman, S. Senn, V.P. Torchilin, J. Drug Target. 21(10), 994 (2013)
J. Liu, Y. Huang, A. Kumar, A. Tan, S. Jin, A. Mozhi, X.-J. Liang, Biotechnol. Adv. 32(4), 693 (2014)
D.C. Manatunga, R.M. de Silva, K.N. de Silva, G.N. Malavige, D.T. Wijeratne, G.R. Williams, P.V. Udagama, Eur. J. Pharm. Biopharm. 128, 18–26 (2018)
X. Zhao, Q. Chen, W. Liu, Y. Li, H. Tang, X. Liu, X. Yang, Int. J. Nanomedicine. 10, 257 (2015)
D. Laha, K. Pal, A.R. Chowdhuri, P.K. Parida, S.K. Sahu, K. Jana, P. Karmakar, New J. Chem. 43(1), 217–229 (2019)
R.K. Thapa, J.H. Kim, J.-H. Jeong, B.S. Shin, H.-G. Choi, C.S. Yong, J.O. Kim, Colloids Surf. B. 153, 95–103 (2017)
J. Zhang, J. Li, Z. Shi, Y. Yang, X. Xie, S.M. Lee, Y. Wang, K.W. Leong, M. Chen, Acta Biomater. 58, 349 (2017)
Acknowledgements
The authors express their gratitude to the Research Council of the Shahid Bahonar University of Kerman, Kerman (Iran), for financial support during the course of this project.
Funding
The author(s) received no specific funding for this work
Author information
Authors and Affiliations
Contributions
S-S J contributed to investigation, data collection, and writing-original draft. A B-D contributed to conceptualization, investigation, supervision, writing, review, and editing. Z K contributed to conceptualization, supervision, and writing—review and editing. G S contributed to conceptualization and writing—review and editing.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest
Availability of data and materials
No additional data are available.
Consent to participate
Informed consent was obtained from all individual participants included in.
the study.
Consent to publish
The current research has no involved human participants and/or animal models.
Informed consent
All authors declare that the current paper has not been under review by other.
Journal, besides approving its submission on Applied Biochemistry and Biotechnology.
Rights and permissions
About this article
Cite this article
Jalaladdiny, Ss., Badoei-dalfard, A., Karami, Z. et al. Co-delivery of doxorubicin and curcumin to breast cancer cells by a targeted delivery system based on Ni/Ta core-shell metal-organic framework coated with folic acid-activated chitosan nanoparticles. J IRAN CHEM SOC 19, 4287–4298 (2022). https://doi.org/10.1007/s13738-022-02604-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13738-022-02604-w